MRNA
Moderna, Inc.
MRNA
Moderna, Inc.
Drug pricing is back on the front page, and healthcare investors have barely flinched. The White House's latest round of most-favored-nation pricing agreements brought nine more manufacturers into the
CNBC's Jim Cramer said August was a comeback month for stocks that had been battered by bearish narratives. Enterprise software staged a particularly strong recovery as Palantir, Veeva, Salesforce, an
Moderna, Revolution Medicines, and Amgen are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that develop
Drug stock Novavax Inc (NASDAQ:NVAX) is trading 2.8% lower at $9.18 this afternoon, pulling back from yesterday's surge to six-week highs.
This article was written by Doug Nathman, with research by his team at Trefis.
Retail investors talked up five hot stocks during the week (Aug. 17 to Aug. 21) on X and Reddit's r/WallStreetBets, driven by retail hype, earnings, AI infrastructure momentum, and corporate news flow
A handful of earnings stragglers and minutes from July's Federal Reserve's meeting made their way across Wall Street this week, the latter of which showed support for an interest rate hike is growi
It's not every day that a company already worth billions sees its shares nearly triple in a single trading session. Welcome to the world of biotech, because that's exactly what happened to Moderna Inc
Virtus Biotech ETF (BBP) is rated a buy for its focused exposure to FDA-approved biotech firms and strong recent outperformance. BBP's equal-weight, quarterly rebalancing strategy efficiently captures
$51.5 billion. That's Moderna's market valuation as of Thursday, marking a more than $18 billion decline from Wednesday's closing valuation of $69.6 billion.
As Moderna Inc. (NASDAQ: MRNA) stock spiked sharply on August 19, catalyzed by positive late-stage trial results for its personalized mRNA (messenger ribonucleic acid) cancer vaccine; $1,000 invested
BioNTech SE (NASDAQ:BNTX) stock is trading higher on Wednesday. Investors are probably reacting to Merck & Co Inc. (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) topline data from individualized cancer th
US stocks rise as Treasury doubles long-bond buybacks, cutting yields and lifting the S&P 500 while Moderna soars on positive late-stage cancer vaccine data.
Moderna Inc (NASDAQ:MRNA) is powering up the Nasdaq this morning, last seen126.5% higher to trade at $142.61.
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial. The combination regimen met the main study goal of significantly
"Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors. This approval also reflects the ongoing potential of our mRNA platform,” Modern
Moderna, Inc. (MRNA) Q2 2026 Earnings Call Transcript
Subscribers to Schaeffer's Weekend Trader options recommendation service received this UAL commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry an
Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF